First Personal Financial Services Biomarin Pharmaceutical Inc Transaction History

First Personal Financial Services

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 15, 2019	SELL	$67.4 - $85.11 $16,513 - $20,851	-245 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$80.35 - $93.9 $642 - $751	-8 Reduced 3.16%	245 $21,000
Q1 2019 Apr 22, 2019	BUY	$84.2 - $98.62 $1,684 - $1,972	20 Added 8.58%	253 $22,000
Q4 2018 Jan 30, 2019	BUY	$80.14 - $106.07 $1,442 - $1,909	18 Added 8.37%	233 $20,000
Q3 2018 Nov 01, 2018	BUY	$93.92 - $105.72 $4,414 - $4,968	47 Added 27.98%	215 $21,000
Q2 2018 Aug 07, 2018	SELL	$76.01 - $99.03 $27,363 - $35,650	-360 Reduced 68.18%	168 $16,000
Q1 2018 May 10, 2018	SELL	$77.67 - $92.63 $10,951 - $13,060	-141 Reduced 21.08%	528 $43,000
Q4 2017 Jan 25, 2018	BUY	$80.76 - $95.13 $12,517 - $14,745	155 Added 30.16%	669 $60,000
Q3 2017 Nov 01, 2017	BUY	$80.6 - $94.95 $41,428 - $48,804	514	514 $48,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of First Personal Financial Services, based on Form 13F filings with the SEC.

Stay updated on First Personal Financial Services with notifications on news.